APA (7th ed.) Citation

Edae, C. K., Bedada, A. T., Teklemariam, M. D., Tolesa, M. B., & Gebre, S. G. (2026). A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia. PLoS ONE, 21(2), 1. https://doi.org/10.1371/journal.pone.0340457

Chicago Style (17th ed.) Citation

Edae, Chala Kenenisa, Abdisa Tufa Bedada, Maria Degef Teklemariam, Mesfin Bekele Tolesa, and Solomon Genet Gebre. "A Prospective Evaluation of Johnson & Johnson COVID-19 Vaccine on Glycemic Biomarkers in Type 2 Diabetes Mellitus in Ethiopia." PLoS ONE 21, no. 2 (2026): 1. https://doi.org/10.1371/journal.pone.0340457.

MLA (9th ed.) Citation

Edae, Chala Kenenisa, et al. "A Prospective Evaluation of Johnson & Johnson COVID-19 Vaccine on Glycemic Biomarkers in Type 2 Diabetes Mellitus in Ethiopia." PLoS ONE, vol. 21, no. 2, 2026, p. 1, https://doi.org/10.1371/journal.pone.0340457.